financetom
Business
financetom
/
Business
/
Akari Therapeutics Names Samir Patel Chief Executive
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Akari Therapeutics Names Samir Patel Chief Executive
Dec 18, 2024 8:39 AM

11:15 AM EST, 12/18/2024 (MT Newswires) -- Akari Therapeutics ( AKTX ) said Wednesday it has named Samir Patel chief executive, effective Dec. 16.

Patel served as interim CEO of Akari Therapeutics ( AKTX ) since May. He currently serves as founder and principal of PranaBio Investments.

Price: 1.01, Change: +0.01, Percent Change: +1.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Palantir Technologies Unusual Options Activity
Palantir Technologies Unusual Options Activity
Dec 18, 2024
Whales with a lot of money to spend have taken a noticeably bullish stance on Palantir Technologies ( PLTR ). Looking at options history for Palantir Technologies ( PLTR ) we detected 52 trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 40% with...
Looking At Caterpillar's Recent Unusual Options Activity
Looking At Caterpillar's Recent Unusual Options Activity
Dec 18, 2024
Investors with a lot of money to spend have taken a bearish stance on Caterpillar ( CAT ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big...
Akari Therapeutics Names Samir Patel Chief Executive
Akari Therapeutics Names Samir Patel Chief Executive
Dec 18, 2024
11:15 AM EST, 12/18/2024 (MT Newswires) -- Akari Therapeutics ( AKTX ) said Wednesday it has named Samir Patel chief executive, effective Dec. 16. Patel served as interim CEO of Akari Therapeutics ( AKTX ) since May. He currently serves as founder and principal of PranaBio Investments. Price: 1.01, Change: +0.01, Percent Change: +1.01 ...
3M's Initial Full-Year Outlook Seen 'Better Than Feared,' UBS Says
3M's Initial Full-Year Outlook Seen 'Better Than Feared,' UBS Says
Dec 18, 2024
11:16 AM EST, 12/18/2024 (MT Newswires) -- 3M's ( MMM ) initial 2025 guidance will likely be better than feared after management's recent comments triggered investor concerns, UBS Securities said Tuesday in a report. UBS estimates buy-side expectations for the industrial conglomerate's 2025 per-share earnings in the $7.50 range, compared with Wall Street's projections for $7.90, driven by $0.30 of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved